T he most important factor leading to amputation for the person with diabetes is peripheral neuropathy and the resulting insensate foot. This leads to painless trauma, ukeration, infection, and finally amputation. Because of the lack of pain, the patient with a foot ulcer is lulled into a false sense of security, perceiving the ulcer to be of little or no significance. Thus the patient neglects and/or delays treatment. I have seen a number of patients with severe painless ukeration who sought medical attention only because they were troubled by the drainage of several weeks' duration. Usually, the spouse noticed the stained socks and bedding and prompted the visit.
Because peripheral neuropathy leads to a high risk for an insensitive foot, the patient must be made aware of the importance of the loss of sensation. Unfortunately, many physicians fail to examine the feet. In two studies, only 16% (1) or 12% (2) of patients' feet were examined, let alone checked for the presence of peripheral neuropathy.
Birke and Rolfsen (3) in this issue of Diabetes Care have provided a unique concept. They demonstrated that patients using the monofilament could accurately check their own feet for the presence or absence of protective sensation. By learning to objectively measure the degree of sensation, the patient becomes a team member in the care of their feet.
While it is not critical in terms of the importance of this article, there are several areas that I would like to have seen covered. It would have been interesting to include a breakdown of the number of each type of provider. How many of these providers were physicians, podiatrists, registered nurses, physical therapists, and/or certified orthotists? Did the performance of the patients differ according to the specialty of the teaching provider? If there were differences, this would identify the persons most qualified to instruct patients in the techniques as well as those least qualified. It was interesting to note that in 23 cases, the patient identified sensory loss, while the provider did not. It would be interesting to know which type of provider missed the diagnosis and/or whether the missed diagnoses were spread equally among all of the teaching providers.
Was there a difference in performance between races? Was there a difference in performance depending on socioeconomic classification of these patients? If so, the provider should be cautioned to pay particular attention to the testing accuracy of this group.
Interestingly, 68% of patients were able to perform the test without assistance. However, this also means 32% required assistance and emphasizes the fact that foot inspection and foot care must be a family undertaking. The need for family assistance becomes even more evident when dealing with older patients who had more difficulty in performing the test.
The article mentions the sites to be tested. However, many providers already are using the monofilament. Therefore, it is important to mention not only the sites that should be tested but also the sites that should not be tested. This would include calluses where test results would not be accurate.
The incorporation of the patient as a team member in evaluating peripheral neuropathy is emphasized in this study, giving the patient the opportunity to do more than merely look at their feet. Loss of sensation of the feet can play an important role in the patient's realization that they might have a high risk for foot insensitivity. This awareness would intensify their involvement in their own care and would include more frequent foot inspections, making sure their shoes were fitted properly and keeping appointments with their health care professional. The bottom line would be a decrease in the number of amputations.
Today's managed care environment leaves very little time for total care of the patient with a chronic disease. Diabetes is a prime example. It is impossible for the physician to take an adequate history, to examine the feet, to check for peripheral neuropathy and vascular disease, and to educate the patient in the allotted time of only 15 min. Reports in managed care settings indicate that a high percentage of patients did not have foot inspections, let alone sensory evaluations. For example, in one managed care plan, 40% of patients did not have a documented foot examination (4) . In another HMO (5), examination of the foot was not noted for 94% of patients.
Failure to note the examination does not necessarily mean the examination was not done. However, the old adage says that if you did not write it down, it was not done. Thus, delegating an important part of the foot examination to the patient, the checking for peripheral neuropathy can become very important in a managed care setting.
Birke and Rolfsen (3) are to be congratulated for incorporating what, up to now, has been an office and clinic procedure into a home care procedure. I think that the end result for patients doing their own home sensory examination will be better foot care and ultimately fewer amputations.
Their caveat that the self-administered sensory test must not replace foot evaluations by a provider is extremely important. An important factor is that the monofilament is very inexpensive. I would have liked the authors to note where and how the monofilament can be obtained. Where can providers obtain instruction kits?
Using this technique in evaluating their own peripheral neuropathy makes the patients more responsible members of the team in foot care. Furthermore, they now have the opportunity to make an early diagnosis of loss of protective sensation and to inform their health care specialist at an earlier date. This self-examination will intensify their involvement in their own care.
